Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Neuropathies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02191826
What this trial is testing

Study of SOM0226 in Familial Amyloid Polyneuropathy

Who this might be right for
Familial Amyloid Polyneuropathy (FAP)
SOM Innovation Biotech SA 17
Not applicableUnknownNCT05452850
What this trial is testing

Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis

Who this might be right for
Amyloid CardiomyopathyCongestive Heart FailureChemotherapy Effect
Istanbul University - Cerrahpasa 30
Not applicableUnknownNCT06367842
What this trial is testing

Orthopaedic Specimen Pathology and Early Diagnosis of ATTR Cardiopathy (ATTR-ORTHO)

Who this might be right for
ATTR AmyloidosisCardiopathyCarpal Tunnel Syndrome+3 more
Institut Mutualiste Montsouris 150
Not applicableStudy completedNCT04828928
What this trial is testing

Neuropathy in Patients Monitored for Wild-type TTR Cardiac Amyloidosis (Non-mutated)

Who this might be right for
Wild-type Amyloid Cardiopathy
University Hospital, Bordeaux 65
Early research (Phase 1)Looking for participantsNCT06790394
What this trial is testing

Test-retest Study With [18F]FBB in Cardiac Amyloidosis

Who this might be right for
Cardiac Amyloidosis
Lantheus Germany GmbH 15
Not applicableLooking for participantsNCT07336394
What this trial is testing

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

Who this might be right for
Danon DiseaseFabry DiseaseCardiac Amyloidosis+4 more
Chinese Academy of Medical Sciences, Fuwai Hospital 1,000
Not applicableUnknownNCT06129331
What this trial is testing

Aortic Stenosis and Cardiac Amyloidosis

Who this might be right for
Cardiac AmyloidosisAortic Stenosis
Medical University of Vienna 300
Not applicableUnknownNCT04956965
What this trial is testing

High Resolution Three-dimensional Maps of the Right Chambers in Patient Diagnosed With Cardiac Amyloidosis

Who this might be right for
Cardiac AmyloidosisCardiac Disease
University Hospital Center of Martinique 24
Not applicableEnrolling By InvitationNCT06664866
What this trial is testing

AI Echocardiographic Screening of Cardiac Amyloidosis

Who this might be right for
Cardiac Amyloidosis
Cedars-Sinai Medical Center 500
Not applicableLooking for participantsNCT07232459
What this trial is testing

[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

Who this might be right for
AmyloidCardiac AmyloidosisAmyloidosis+1 more
Tianjin Medical University 25
Not applicableActive Not RecruitingNCT07062848
What this trial is testing

An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.

Who this might be right for
Transthyretin (TTR) Amyloid Cardiomyopathy
Yale University 1,500,000
Not applicableActive Not RecruitingNCT05103943
What this trial is testing

Amyloidosis TTR Flow Reserve Evaluation

Who this might be right for
Amyloid Cardiomyopathy
Centre Hospitalier Régional d'Orléans 50
Not applicableNot Yet RecruitingNCT07538518
What this trial is testing

PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels

Who this might be right for
Amyloidogenic Transthyretin (ATTR) AmyloidosisCardiac Amyloidosis
Lorena Saelices 25
Not applicableNot Yet RecruitingNCT07567508
What this trial is testing

Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)Cardiac Amyloidosis
Samsung Medical Center 500
Very early researchStudy completedNCT03119558
What this trial is testing

PET/MRI Evaluation of Cardiac Amyloid

Who this might be right for
Cardiac Amyloidosis
Stanford University 9
Not applicableLooking for participantsNCT05489549
What this trial is testing

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

Who this might be right for
Amyloidosis, HereditaryAmyloidosis CardiacAmyloidosis, Familial+2 more
University of Texas Southwestern Medical Center 500
Not applicableLooking for participantsNCT07382128
What this trial is testing

Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

Who this might be right for
HCM - Hypertrophic CardiomyopathyAnderson Fabry DiseaseCardiac Magnetic Resonance Imaging+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 250
Not applicableLooking for participantsNCT06907836
What this trial is testing

Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine

Who this might be right for
Cardiac Amyloidosis
University Hospital, Strasbourg, France 30
Post-approval studies (Phase 4)Looking for participantsNCT06940336
What this trial is testing

To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy

Who this might be right for
Transthyretin Amyloid Polyneuropathy
Qilu Pharmaceutical Co., Ltd. 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT07116473
What this trial is testing

To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

Who this might be right for
Amyloidosis in Transthyretin (TTR)Amyloidosis, FamilialAmyloid Cardiomyopathy+7 more
Eidos Therapeutics, a BridgeBio company 250
Next Page